Theorem Clinical Research, a leading contract research organization (CRO) that optimizes trial conduct, will present the webinar, “Adaptive Design in Early-Phase Oncology Trials — Best Practices for Conduct,” at 10 a.m. EST on Nov. 12.
Theorem experts Connie Wierman, MBA, vice president of biopharmaceutical development; Jeff Joseph, senior director of statistics; and Scott Currence, director, service partnerships, will team up with Howard Grossberg, M.D., president of Grossberg Pharmaceutical Consulting and senior oncology medical advisor to Theorem, to discuss best practices for implementing adaptive design for early-phase oncology trials for sites, CROs and sponsors.
Help employers find you! Check out all the jobs and post your resume.
